FDA
approval
· 2024-05-24
FDA Approved: ERLOTINIB — Original Application (Camber Pharmaceuticals, Inc.)
Summary
The FDA approved Camber Pharmaceuticals' original application for Erlotinib (ERLOTINIB), enabling a generic version of the cancer drug to be marketed in the Uni…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ERLOTINIB (ERLOTINIB)